Teva Pharmaceuticals

/Tag: Teva Pharmaceuticals

FDA Approves Teva’s Generic Version of Mylan’s EpiPen

Israel’s Teva Pharmaceuticals shares rallied after the U.S. Food and Drug Administration approved Thursday the company’s generic version of the best-selling, lifesaving allergy injection EpiPen. Although Teva didn’t say when it would begin sales of its product or its price, the approval promises to turn the company into a champion for the millions of Americans who use

Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.

When Teva Pharmaceuticals announced recently that it would begin selling a copycat version of Syprine — an expensive drug invented in the 1960s — the news seemed like a welcome development for people taking old drugs that have skyrocketed in price. Syprine, which treats a rare condition known as Wilson disease, gained notoriety after Valeant Pharmaceuticals